Rating Change
BTIG analysts reiterated a Buy rating on DexCom, Inc. (NASDAQ:DXCM) on July 31, 2026.
reiterateNASDAQ:DXCM
BTIG Reiterates Buy Rating on DexCom, Inc. (DXCM)
Rating Change BTIG analysts reiterated a Buy rating on DexCom, Inc. (NASDAQ:DXCM) on July 31, 2026. Market Context DexCom, Inc.
Market Context
DexCom, Inc. operates in the Healthcare sector. The stock currently trades at $74.54 with a market capitalization of $27.0B. The stock has gained 23.9% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DexCom, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for DexCom, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 31, 2026 | BTIG | Buy | N/A |
| Jul 28, 2026 | UBS | Buy | N/A |
| Jul 16, 2026 | Truist Securities | Buy | N/A |
| Jul 15, 2026 | Mizuho | Outperform | N/A |
| Jun 23, 2026 | Deutsche Bank | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View DXCM Stock Page
Frequently Asked Questions
What does a Buy rating mean for DXCM?
A Buy rating from BTIG reflects the analyst's outlook on DexCom, Inc. (NASDAQ:DXCM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the DXCM forecast page.
